Jim Wassil

Jim Wassil, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vaxcyte, Inc. and Icosavax, Inc. The record holds 61 filings, for trades running from 24 February 2022 to 5 October 2026.

Sales make up the whole of the open-market record (18 sales, €2.7M). Besides market trades, the filings include 12 share grants and 29 option exercises. In 2026 alone, the filings show no purchases and 13 sales.

The record was last updated on 7 October 2026 with an option exercise (€86k) in Vaxcyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.